These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6761766)

  • 1. Patient assessment in clinical trials.
    Guy W
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):601-6. PubMed ID: 6761766
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical clinical issues regarding child and adolescent psychopharmacology.
    Kutcher S
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):245-60. PubMed ID: 10674199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scales for assessment of diagnosis and severity of mental disorders.
    Acta Psychiatr Scand Suppl; 1993; 372():1-87. PubMed ID: 8317228
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic assessment.
    Dunner DL
    Psychiatr Clin North Am; 1993 Sep; 16(3):431-41. PubMed ID: 8415230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the efficacy of psychotropic drugs: clinical symptoms and rating scales.
    Maier W; Bech P
    Psychopharmacol Ser; 1990; 8():105-20. PubMed ID: 2198558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems of documentation of psychopathological symptoms in psychopharmacotherapy.
    Kühne GE; Grünes JU; Pelliccioni R
    Agressologie; 1978; 19(C):125-9. PubMed ID: 751501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Standard methods of evaluating the psychic condition in the clinical assessment of psychotropic drugs].
    Puzyński S
    Psychiatr Pol; 1976; 10(1):15-27. PubMed ID: 943108
    [No Abstract]   [Full Text] [Related]  

  • 9. Appropriate and judicious use of psychotropic medications in youth.
    Stroeh O; Trivedi HK
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):703-11. PubMed ID: 23040897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AMDP-System in pharmacopsychiatry.
    Mod Probl Pharmacopsychiatry; 1983; 20():1-232. PubMed ID: 6621543
    [No Abstract]   [Full Text] [Related]  

  • 11. Some problems in the conduct of psychotropic drug trials (a review).
    Doongaji DR; Parikh MD
    J Postgrad Med; 1983 Apr; 29(2):67-74. PubMed ID: 6631765
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for psychiatric disorders.
    Treat Guidel Med Lett; 2003 Jul; 1(11):69-76. PubMed ID: 15529094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phytotherapeutic drugs in psychiatry].
    Kalus P; Strik WK
    Ther Umsch; 2002 Jun; 59(6):307-12. PubMed ID: 12125180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of drugs used in the management of assaultive inpatients.
    Tardiff K
    Bull Am Acad Psychiatry Law; 1983; 11(3):215-22. PubMed ID: 6640115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Scientific methodology and psychopharmacology].
    Elie R; Ohayon M
    Ann Med Psychol (Paris); 1992; 150(2-3):192-4; discussion 194-5. PubMed ID: 1343517
    [No Abstract]   [Full Text] [Related]  

  • 17. Alexithymia and treatment preferences among psychiatric outpatients.
    Ogrodniczuk JS; Piper WE; Joyce AS; Abbass AA
    Psychother Psychosom; 2009; 78(6):383-4. PubMed ID: 19738407
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and utilization of outcome measures in psychiatric clinical trials. Report on the 1988 MacArthur Foundation Network I Methodology Institute.
    Kraemer HC; Telch CF
    Neuropsychopharmacology; 1992 Sep; 7(2):85-94. PubMed ID: 1418305
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change.
    Pecknold JC; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1976 Jan; 12(1):12-4. PubMed ID: 1246557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.